Japan: A recent study published in Annals of Allergy, Asthma & Immunology has highlighted the potential of the baseline ...

Châtillon, France, October 18, 2024DBV Technologies to Participate in Upcoming ACAAI 2024 CongressDBV Technologies (Euronext: DBV – ISIN: ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that five abstracts have been accepted for e-Poster presentation at the 2024 Annual Sci ...

Tired of sniffling and sneezing, or worse, are allergies getting in the way of you living the life you deserve? Whether your ...

The following is a summary of “A partial loss-of-function variant in STAT6 protects against T2 asthma,” published in the ...

Of the interviewed providers, 53.4% had experience with food allergy clinical trials, and 85% offered oral immunotherapy to ...

They provide expert care for allergy, asthma, and immunology conditions, helping patients find relief and improve their quality of life. Whether you’re dealing with seasonal allergies, asthma, food ...

The recent approval of a new epinephrine nasal spray gives patients a powerful new way to keep life-threatening aller ...

Managing flare-ups begins with identifying and avoiding triggers. If pollen or poor air quality exacerbates your asthma, for ...

Primary care physicians (PCPs) play a key role in treating young patients as they progress through the "atopic march" from ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...